SUMMARY The variability in the orocaecal transit time as measured by the lactulose/breath hydrogen method has been studied for three conditions: lactulose given with a meal, subjects sitting; lactulose given with a meal, subjects semirecumbent; lactulose given in aqueous solution, subjects semirecumbent. Thirty three healthy subjects attended on up to 12 occasions. It was found that administration of the lactulose with a meal significantly reduced the variability (p<005) and that adoption of the semirecumbeut position further reduced variability. A power analysis was used to predict the number of subjects who would be required to show a given percentage change in orocaecal transit time at specified probabilities and powers. A graph and a table for use in the prediction of subject numbers at a probability of 5% and for powers of 50-99% is presented. A dose response curve for metoclopramide using the lactulose/breath hydrogen method is given for doses of 10, 15, and 20 mg.
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Small bowel transit time may be assessed radiologically, by radioisotope labelling of test meals and by use of intubation techniques, although these methodologies may themselves alter transit times and radiation exposure may present ethical problems. The presence of bacterial flora in the large bowel provides a range of possible alternative approaches. Thus the conversion of sulphasalazine to sulphapyridine by bacterial azoreductase with assay of this metabolite in blood,' the production of hydrogen from the raffinose and stachyose content of a baked bean meal or the hydrogen obtained from sorbitol2 or lactulose (galactosido-fructose) have all been described.
The lactulose breath hydrogen (L/BH) test described by Bond and Levitt3'4 is now in widespread use, but only limited application of the method to assess drug activity has been made. is the probability with which the familiar p value is compared when a test is performed. A type II error is made by not rejecting the null hypothesis when it is in fact false. The probability of a type II error (the beta level) is closely related to the power (1-beta) of the test. Hence the power is the probability of detecting a difference when one really exists.
A compromise has to be made between the probabilities of the two types of error. Both types of error must therefore be considered in our evaluation.
In the investigations reported here the inter and intrasubject variation in small bowel transit time, assessed by use of the lactulose/breath hydrogen method, has been studied. Statistical analysis of these data have been undertaken to find the number of patients who would be required to show differences of specified magnitude at conventional levels of significance and power. This method has been found useful in assessing novel gastrokinetic agents and a dose response curve for metoclopramide is presented.
Methods

GENERAL METHODOLOGY
Normal healthy subjects attended on 12 occasions separated by intervals of not less than three days, usually weekly. They were fasting and had abstained from beer and those foods rich in non-utilisable sugars -for example, beans, during the previous 24 hours. After a 30 minute period to obviate the stress of travel, subjects were seated and breath samples taken for determination of, hydrogen content every 10 min for one hour, the mean of these readings providing the baseline value. The lactulose (20 ml lactulose solution BP which has 3-35 g/5 ml) was then given either in water (50 ml) or rice pudding (220 g Ambrosia creamed rice) as required by the experiment. Breath samples were then taken at 10 minute intervals until a rise of 15 ppm above the baseline value was noted; this being the end point. If a rise was noted of less than 15 ppm the frequency of breath sampling was increased to every five minutes. Breath samples were taken at end expiration using a T-tube connected to 1-5 m Silastic tubing (0-6 mm id). Samples were taken with a 20 ml syringe and assayed for the hydrogen content immediately.
ASSAY OF BREATH HYDROGEN
Breath hydrogen was assayed using an electrochemical technique. The hydrogen meter has an accuracy of ±2% and a repeatability of ±1 ppm (Gas Measurement Ltd, Renfrew, Scotland). The hydrogen meter was calibrated each day using a known source of 96 ppm.
INTER AND INTRASUBJECT VARIABILITY
Three separate experiments (1, 2, 3) were carried out to assess the inter and intrasubject variation in orocaecal transit time using the lactulose/breath hydrogen method with the conditions outlined in Table 1 
Results
INTER AND INTRASUBJECT VARIATION WITH THE LACTULOSE METHOD SITTING WITH A MEAL
The results are presented in Table 2 which shows the transit time in minutes for 11 subjects attending on 12 occasions.
INTER AND INTRASUBJECT VARIATION WITH THE LACTULOSE METHOD SEMIRECUMBENT WITH A MEAL
The results are presented in Table 3 which shows the transit time in minutes for 10 subjects attending on 12 occasions. 
INTER AND INTRASUBJECT VARIATION WITH THE LACTULOSE METHOD SITTING, AQUEOUS SOLUTION
The results are presented in Table 4 which shows the transit time in minutes for 12 subjects attending on 12 occasions.
ESTIMATION OF SAMPLE SIZE
It is desired to calculate the number of patients/ subjects who would be required to show a given percentage change in orocaecal transit time at a level of significance and power which is statistically acceptable. The data on inter and intra subject variation presented in the tables above were first log transformed and then subjected to analysis of variance to obtain estimates of the relevant population variance for paired samples. The following formula enables calculation of the number of patients/subjects required using standard methods:6'
Where Z is the normal distribution integral (found from tables or calculated by a formula.8 Thus if the power selected was 80%, beta=0-2 and Z(beta)= 0-85. P is the percentage change.
The required population variance (V) obtained as described above is 0-01953 for patients sitting and lactulose given with a meal, 0-01623 for patients semirecumbent, lactulose given with a meal, 0-03712 for patients sitting and receiving lactulose in aqueous solution.
Finally a small correction is required6 to compensate for the necessary use of the normal distribution to approximate to the ideal t distribution. Add 2 on to N for alpha values of 5%, and 3 for 1%.
Using this formula the number of subjects who would be needed to show percentage changes of 10 to 50% in transit time for probabilities of 5% and 1% at two statistical power levels have been calculated and are shown in Table 5 below. Figure 1 shows the number of subjects who would be needed to show percentage changes in the OCTT for a range of powers of (50-99%) at a probability of 5%. Alpha level  1%  5%  1%  5%  1%  5%   1%  5%  1%  5%  1%  5%   Percent  10  137  92  207  151  114  77  172  126  257  173  390  284  difference 20  40  27  59  43  34  23  50  36  73  49  109  79  30  21  14  30  22  18  12  26  19  37  25  54  40  40   14  10  20  14  12  8  17  12  24  16  34  25  50  11  7  15  11  10  7  13  9  17  12  25 The mean breath hydrogen concentrations after placebo or metoclopramide are shown in Figure 2 and the mean OCT-F's are given in Table 6 . The orocaecal transit times found after the three doses of metoclopramide and placebo were subjected to a two way analysis of variance after a log trans- reasonable but found wide intersubject variation in the extent and duration of the rise. When using the L/BH method to assess changes brought about in the OCTT by pharmacological agents or diet as many factors as possible need to be standardised and the cross over design used whenever practicable. The suggestion"2 that better reproducibility might be found by combining the lactulose with a meal is confirmed by the above studies.
Comparison of the analyses of variance for the OCTI after administration of the lactulose with a meal as opposed to administration in aqueous solution shows the variability to be significantly reduced (p<0-001). Furthermore adopting the semirecumbent posture during the test, as opposed to sitting, provides further reduction in variability though this was not statistically significant (p>005).
In conclusion the variability in the lactulose/breath hydrogen test is not so great as to prevent the use of the method in assessing the action of drugs in suitably designed crossover studies using relatively small groups of patients if these are likely to produce an effect of size sufficient to have clinical significance. The dose response study for metoclopramide illustrates this; with 16 subjects activity at, at least, the 5% level of significance was shown. The practical implication of this work is that having quantified the variability in the OCTT when measured by the L/BH method the number of patients/subjects who should be included in a study to produce statistically useful results can now be forecast provided one has an idea of the magnitude of the change expected.
